Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis

Volume: 28, Issue: 9, Pages: 966 - 972
Published: Oct 4, 2019
Abstract
The Comparison of Sacubitril-Valsartan versus Enalapril on Effect on NT-proBNP in Patients Stabilised from an Acute Heart Failure Episode (PIONEER-HF) trial demonstrated significant reductions in N-terminal pro-B-type natriuretic peptide. Our study explored the cost-effectiveness of the use of sacubitril-valsartan versus enalapril in acute decompensated heart failure from the Australian healthcare perspective.A Markov model was designed using...
Paper Details
Title
Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis
Published Date
Oct 4, 2019
Volume
28
Issue
9
Pages
966 - 972
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.